Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. - Wikidata - awgldk - TriplyDB

Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.

Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.

http://www.wikidata.org/entity/Q36090174

about

Antiviral drugs for viruses other than human immunodeficiency virus Respiratory virus modulation of host nucleocytoplasmic transport; target for therapeutic intervention?Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.Clinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: a single-center experience.The role of donor chronic alcohol abuse in the development of primary graft dysfunction in lung transplant recipients.Gastroesophageal reflux disease is associated with an increased rate of acute rejection in lung transplant allografts.Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores.Viral infections in lung transplant recipients.Monitoring and managing viral infections in pediatric renal transplant recipients.Respiratory viruses in lung transplant recipients: a critical review and pooled analysis of clinical studies.Management of viral infections in solid organ transplant recipients.Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients.Lung transplant infection.Opportunistic viral infections in intestinal transplantation.Respiratory syncytial virus: current and emerging treatment options Oral Ribavirin for the Treatment of Noninfluenza Respiratory Viral Infections: A Systematic Review.Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state.Update in the treatment of non-influenza respiratory virus infection in solid organ transplant recipients.Antiviral activity of diarylheptanoid stereoisomers against respiratory syncytial virus in vitro and in vivo.Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients.Receptor for advanced glycation end products in donor lungs is associated with primary graft dysfunction after lung transplantation.Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation.Novel antiviral agents for respiratory viral infection in immunocompromised adults.RNA respiratory viruses in solid organ transplantation.Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation.Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin.Prevention of chronic rejection after lung transplantation.RSV prevention and treatment in pediatric lung transplant patients: a survey of current practices among the International Pediatric Lung Transplant Collaborative.RNA interference, RSV, and lung transplantation: a promising future for siRNA therapeutics.

P2860

Q24635330-01C67ED6-8293-4997-96A4-84B8C26C943A Q26796151-B00A75B2-6EBE-41AB-A944-87FC16525D73 Q28474617-0C9D1019-E30D-4B6E-955B-CA1CF3A6C6B2 Q30240274-C5117FE5-EABA-4705-A299-15886A6599F2 Q30409593-202A1A5A-ECF7-4A39-B6FC-D9B829CE045D Q35033561-C4C520A7-8442-4DF9-B236-97F827D5146B Q36090235-AE50B92A-00D3-43FD-B3F7-97AE136543AA Q36558322-A7B116A6-6E83-4420-B6D9-7520AA2DC178 Q37721885-7ADECD08-6C24-4237-937E-ABC4DE47F6E6 Q37848137-3618B693-EC0B-4849-B3C4-A742D7F617D9 Q37869227-88F3032C-F574-4C0A-B5DF-EB0268593A32 Q37892559-6F7305D9-C2D5-4F94-8B46-BF02B984F056 Q37991125-DB497174-B8ED-4BB0-BC36-70B0FF59ECF0 Q38010486-F8A43BC2-F98F-4DF5-B2D1-B3E745DCDA09 Q38097119-76A766DC-E081-468D-8CE3-AB4EF768886D Q38210541-BD100DAF-D984-42CD-864C-24919C13A6B5 Q38558150-18E025E9-6737-4AAF-A6E9-D87C110C5BC4 Q38702032-2105A21D-4A87-49A4-A9B1-D9E09B92BB4F Q38829076-DD218F29-F391-4A0A-9BC4-128270301FEC Q39205730-18BD97CF-5C97-41FA-9B17-8EDCFA094011 Q39962070-169ECE09-3FC2-4420-B9D6-DF4988268FF8 Q40214692-A62CB3FC-EF8C-4C48-B104-4C55EEDB38EF Q40598542-7B1CD8A5-6A01-400E-A5E5-32E14732D2B1 Q41166298-DBFCCFF9-EF08-4580-8264-F83D04A6CCC2 Q42243405-F4A57957-7745-4165-A5A0-FD85F35CABF0 Q42272300-4972564A-E08A-44B2-9F01-2C271410E57A Q42279293-54F20CB4-E7D3-4FCA-BF9E-490E6881B1D5 Q45358049-F0467D04-6F6E-4F90-8B0E-A03690C0FE11 Q47662940-5C3DDC5D-12B8-45A0-B588-482BF0F50228 Q50551742-906A6042-67EE-4570-BBE1-5C8F0F317C03 Q51729146-56591C22-00CA-4D9F-8F40-CB3114689412

P2860

Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.

http://www.wikidata.org/entity/Q36090174

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Efficacy of oral ribavirin in ...... r respiratory tract infection.

@ast

Efficacy of oral ribavirin in ...... r respiratory tract infection.

@en

type

label

Efficacy of oral ribavirin in ...... r respiratory tract infection.

@ast

Efficacy of oral ribavirin in ...... r respiratory tract infection.

@en

prefLabel

Efficacy of oral ribavirin in ...... r respiratory tract infection.

@ast

Efficacy of oral ribavirin in ...... r respiratory tract infection.

@en

P1433

Q36090174-7ECEEDDC-1606-4F1C-94FA-852432D603F1

P1476

Q36090174-884EF1DE-F18F-4744-AE4B-8AE8E94EDF53

P2093

Q36090174-1486268C-A4A3-475C-B9B1-8ABC6DF6B25C

Q36090174-389C6F84-724D-48EA-874A-8F9FD8BF95C6

Q36090174-3C1329E8-AB0D-4008-BC2E-516BF768BD74

Q36090174-6B0611A6-7700-4B39-AEB0-17CE7182FF7D

Q36090174-C448F6D8-B737-4E0B-A254-372FC3B2E7F5

Q36090174-C8E13F83-5DF1-4428-8B40-692BF1F6F43A

Q36090174-CB1983A3-EE22-4CE8-B180-799171C3BF31

Q36090174-D7ACE897-F60D-4274-BA9B-2708109D3201

Q36090174-DCB9E2D6-0BC4-49CD-9648-526421EEF76E

Q36090174-F13B9E06-3AE9-4842-BB0F-E0DC2D0E5E66

P2860

Q36090174-02840518-A3CD-46E5-A5F6-53181C26722B

Q36090174-33A3B602-1B43-437C-A086-D96544BA503E

Q36090174-37C294A5-2605-46A3-87C2-B6395E1E13C8

Q36090174-45DED4CA-9622-4768-A9F8-CE97EB4BECC7

Q36090174-527C3AC6-B2D7-470C-A32B-FFE94A4D013C

Q36090174-71DDAFD8-E8FC-41E8-8A9B-8E1D96AD12FD

Q36090174-87B9699D-FDFD-4930-A037-DDCA5F21D00F

Q36090174-B14E4D54-D1C6-4166-9C54-A44F93741D9C

Q36090174-C9337D76-FAB7-41F8-B066-F02B4BEA85F0

Q36090174-EE21DAA0-E188-4468-8C8F-3786E46D368C

P304

Q36090174-7761CFDF-3F7F-464E-BA4C-27BC6116B37C

P31

Q36090174-36866B60-79B3-4CFC-9EB8-F4CC56CCA6BD

P356

Q36090174-28763607-6112-4A4D-9B9D-FA73E91B63C7

P433

Q36090174-08D73E17-3B24-47FB-AEE6-03A0C454CF1F

P478

Q36090174-C4BD8314-DB2E-4FD0-A1A8-2DFAE4249F1A

P577

Q36090174-3EA36127-3068-4D71-A4A0-9F8FE4E96C18

P5875

Q36090174-0B584B74-89E2-4CFB-9D86-6C46A5DE9DD3

P698

Q36090174-EAD35DBE-DBB3-48FB-A131-63FFF8B9A592

P921

Q36090174-88994EB4-465F-4AC6-86B0-DA7F5C126D35

P932

Q36090174-1702209F-F632-408C-8577-FF31C0582588

P356

J.HEALUN.2008.10.008

P1433

The Journal of Heart and Lung Transplantation

P1476

Efficacy of oral ribavirin in ...... r respiratory tract infection.

@en

P2093

Allan M Ramirez

http://www.w3.org/2001/XMLSchema#string

Andres Pelaez

http://www.w3.org/2001/XMLSchema#string

Anthony A Gal

http://www.w3.org/2001/XMLSchema#string

David C Neujahr

http://www.w3.org/2001/XMLSchema#string

E Clinton Lawrence

http://www.w3.org/2001/XMLSchema#string

G Marshall Lyon

http://www.w3.org/2001/XMLSchema#string

Marianne Foster

http://www.w3.org/2001/XMLSchema#string

Patrick O Mitchell

http://www.w3.org/2001/XMLSchema#string

Priyumvada M Naik

http://www.w3.org/2001/XMLSchema#string

Seth D Force

http://www.w3.org/2001/XMLSchema#string

P2860

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.

Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: case report and review of the literature.

Respiratory viral infections in transplant recipients.

Community respiratory viral infection in adult lung transplant recipients.

Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.

Brief report: respiratory syncytial virus activity--United States, July 2006-November 2007.

Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.

CT manifestations of respiratory syncytial virus infection in lung transplant recipients.

Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin.

Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant.

P304

67-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HEALUN.2008.10.008

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23769252

http://www.w3.org/2001/XMLSchema#string

P698

19134533

http://www.w3.org/2001/XMLSchema#string

P921

lung transplant

P932

3395057

http://www.w3.org/2001/XMLSchema#string